{"url_path":"/sec/om/8-k/2026-06-05/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-05","source_url":"https://www.sec.gov/Archives/edgar/data/1484612/0001193125-26-259527-index.html","accession_number":"0001193125-26-259527","cik":"0001484612","ticker":"OM","issuer_name":"Outset Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1484612/0001193125-26-259527-index.html","primary_entity_key":"0001484612","primary_entity_name":"Outset Medical, Inc."},"word_count":379,"has_tables":true,"body_markdown":"Item 5.07. Submission of Matters to a Vote of Security Holders.\n\nOn June 4, 2026, the Company held its Annual Meeting of Stockholders at 1:30 p.m. Pacific Time in a virtual format via live audio webcast (the “Annual Meeting”). As of April 9, 2026, the Company’s record date, there were a total of 18,529,233 shares of common stock outstanding and entitled to vote at the Annual Meeting. At the beginning of the Annual Meeting, 13,890,864 shares of common stock were present virtually in person or by proxy, and, therefore, a quorum was present. Three items of business were acted upon by the stockholders at the Annual Meeting. The final results for the votes regarding each proposal are set forth below.\n\nProposal One: Election of Class III Directors\n\nEach of Brent D. Lang and Karen Prange was elected to serve as a class III director to hold office until the Company’s 2029 annual meeting of stockholders and until the election and qualification of his or her successor. Votes were cast as follows:\n\nFor\n\nWithheld\n\nBroker Non-Votes\n\nBrent D. Lang\n\n8,109,357\n\n2,642,698\n\n3,138,809\n\nKaren Prange\n\n10,317,822\n\n434,233\n\n3,138,809\n\nSince the Board is divided into three classes with one class elected each year to hold office for a three-year term, the following directors continued to serve as directors of the Company immediately after the Annual Meeting: Karen Drexler, D. Keith Grossman, Patrick T. Hackett, Kevin O’Boyle and Leslie Trigg.\n\nProposal Two: Advisory Vote on Named Executive Officer Compensation\n\nThe proposal to approve the 2025 compensation of the Company’s named executive officers as disclosed in its 2026 proxy statement on a non-binding advisory basis was approved by the following vote:\n\nFor\n\nAgainst\n\nAbstain\n\nBroker Non-Votes\n\n7,548,774\n\n3,196,870\n\n6,411\n\n3,138,809\n\nProposal Three: Ratification of Appointment of Independent Registered Public Accounting Firm\n\nThe stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 by the following vote:\n\nFor\n\nAgainst\n\nAbstain\n\nBroker Non-Votes\n\n13,554,287\n\n20,047\n\n316,530\n\n—\n\n \n\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\nOutset Medical, Inc.\n\n \n\nDate: June 5, 2026\n\nBy:\n\n/s/ John Brottem\n\nJohn Brottem\n\nGeneral Counsel"}